Cephalexin and Trilipix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin (cephalexin) and Trilipix (choline fenofibrate). Common drug interactions include blood uric acid increased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cephalexin and Trilipix. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.

What is Trilipix?

Trilipix has active ingredients of choline fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 5,915 Trilipix users. Check the latest studies of Trilipix.



On Jul, 07, 2026

67 people who take Cephalexin and Trilipix together, and have interactions are studied.

Cephalexin and Trilipix drug interactions.

What are the common drug interactions of Cephalexin and Trilipix, by gender? *:

female:

  1. Blood uric acid increased
  2. Bone disorder
  3. Cardiac arrest
  4. Cardiac failure
  5. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
  6. Death
  7. Decreased appetite
  8. Disease progression
  9. Fall
  10. Hand fracture

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Bone density decreased
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Abscess (pus)
  6. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  7. Bipolar disorder (mood disorder)
  8. Death
  9. Drug dependence
  10. Hip fracture

What are the common drug interactions of Cephalexin and Trilipix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Nephropathy (damage to or disease of a kidney)
  6. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Abscess (pus)
  2. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  3. Bone density decreased
  4. Death
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Renal impairment (severely reduced kidney function)
  9. Scrotal abscess (pus in scrotum)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Abdominal adhesions (inflammation of abdomen)
  4. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  5. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  6. Ankle fracture
  7. Anxiety
  8. Aphonia (inability to produce voice)
  9. Arrhythmia (irregular heartbeat)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 48 people, 71.64%
  2. Pain: 32 people, 47.76%
  3. High Blood Pressure: 32 people, 47.76%
  4. Diabetes: 32 people, 47.76%
  5. Stress And Anxiety: 24 people, 35.82%
  6. Multiple Allergies (allergy to multiple agents): 17 people, 25.37%
  7. Depression: 15 people, 22.39%
  8. Blood Pressure Abnormal: 14 people, 20.90%
  9. Inflammation: 13 people, 19.40%
  10. Cardiac Disorder: 12 people, 17.91%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Trilipix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cephalexin and Trilipix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cephalexin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Trilipix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cephalexin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trilipix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cephalexin and choline fenofibrate (the active ingredients of Cephalexin and Trilipix, respectively), and Cephalexin and Trilipix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: